Opioid-induced constipation in intensive care patients: Relief in sight?

Critical Care

Volumn 12, Issue 4, 2008, Pages

  Chappell, Daniel ^a   Rehm, Markus ^a   Conzen, Peter ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ACETYLCHOLINE; ALVIMOPAN; BISACODYL; HERBACEOUS AGENT; LAXATIVE; OPIATE; OSMOTIC AGENT; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANALGESIC ACTIVITY; BRADYCARDIA; CAUSAL ATTRIBUTION; CONSTIPATION; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; INTENSIVE CARE UNIT; NOTE; PAIN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT SECRETION; SEDATION; SENNA; SIDE EFFECT; TREATMENT INDICATION; TREATMENT RESPONSE; CHEMICALLY INDUCED DISORDER; EDITORIAL; INTENSIVE CARE; METHODOLOGY;

ANALGESICS, OPIOID; CONSTIPATION; HUMANS; INTENSIVE CARE; NARCOTIC ANTAGONISTS;

EID: 65849188545     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6930     Document Type: Note

References (12)

1. Mutlu GM Mutlu EA Factor P GI complications in patients receiving mechanical ventilation Chest 2001, 119:1222-1241. 10.1378/ chest.119.4.1222 11296191
2. Nguyen NQ Ng MP Chapman M Fraser RJ Holloway RH The impact of admission diagnosis on gastric emptying in critically ill patients Crit Care 2007, 11:R16. 2151889 17288616 10.1186/cc5685
3. Reintam A Parm P Redlich U Tooding LM Starkopf J Köhler F Spies C Kern H Gastrointestinal failure in intensive care: A retrospective clinical study in three different intensive care units in Germany and Estonia BMC Gastroenterol 2006, 6:19. 1513588 16792799 10.1186/ 1471-230X-6-19
4. Thomas J Opioid-induced bowel dysfunction J Pain Symptom Manage 2008, 35:103-113. 10.1016/j.jpainsymman.2007.01.017 17981003
5. Mostafa SM Bhandari S Ritchie G Gratton N Wenstone R Constipation and its implications in the critically ill patient Br J Anaesth 2003, 91:815-819. 10.1093/bja/aeg275 14633751
6. Thomas J Karver S Cooney GA Chamberlain BH Watt CK Slatkin NE Stambler N Kremer AB Israel RJ Methylnaltrexone for opioid-induced constipation in advanced illness N Engl J Med 2008, 358:2332-2343. 10.1056/NEJMoa0707377 18509120
7. Yuan CS Foss JF Oral methylnaltrexone for opioid-induced constipation JAMA 2000, 284:1383-1384. 10.1001/jama.284.11.1383 10989399
8. Yuan CS Doshan H Charney MR O'Connor M Karrison T Maleckar SA Israel RJ Moss J Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans J Clin Pharmacol 2005, 45:538-546. 10.1177/0091270004273491 15831777
9. Berde C Nurko S Opioid side effects - mechanism-based therapy N Engl J Med 2008, 358:2400-2402. 10.1056/NEJMe0801783 18509126
10. Liu M Wittbrodt E Low-dose oral naloxone reverses opioid-induced constipation and analgesia J Pain Symptom Manage 2002, 23:48-53. 10.1016/ S0885-3924(01)00369-4 11779668
11. Liu SS Hodgson PS Carpenter RL Fricke JR Jr ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia Clin Pharmacol Ther 2001, 69:66-71. 10.1067/mcp.2001.112680 11180040
12. Spoel van der JI Schultz MJ Voort van der PH de Jonge E Influence of severity of illness, medication and selective decontamination on defecation Intensive Care Med 2006, 32:875-880. 10.1007/ s00134-006-0175-9 16715327